Cesarean Section

Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery

Treatment Outcome / Oxytocin / Prospective studies / Pregnancy / Humans / Female / Gynecology and Obstetrics / MISOPROSTOL / Adult / Cesarean Section / Pilot Projects / Blood Loss / Postpartum Hemorrhage / Female / Gynecology and Obstetrics / MISOPROSTOL / Adult / Cesarean Section / Pilot Projects / Blood Loss / Postpartum Hemorrhage

Multiple laparotomic myomectomy during pregnancy: a case report

Pregnancy / Case Report / Humans / Female / Risk factors / Adult / Cesarean Section / Risk Factors / Preterm Delivery / Leiomyoma / Live birth / Adult / Cesarean Section / Risk Factors / Preterm Delivery / Leiomyoma / Live birth

A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: The PIVOT trial

Treatment Outcome / Pregnancy / Humans / Female / Hydralazine / Adult / Public health systems and services research / Cesarean Section / Magnesium Sulfate / Diazoxide / cardiotocography / Adult / Public health systems and services research / Cesarean Section / Magnesium Sulfate / Diazoxide / cardiotocography

Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery

Treatment Outcome / Oxytocin / Prospective studies / Pregnancy / Humans / Female / Gynecology and Obstetrics / MISOPROSTOL / Adult / Cesarean Section / Pilot Projects / Blood Loss / Postpartum Hemorrhage / Female / Gynecology and Obstetrics / MISOPROSTOL / Adult / Cesarean Section / Pilot Projects / Blood Loss / Postpartum Hemorrhage

Implantation Despite an Extensive Endometrial Defect after Hysteroscopic Resection of Symptom-Free Residual Trophoblastic Tissue 15 Months after Cesarean Section

Pregnancy / Humans / Female / Embryo Transfer / Hysteroscopy / Adult / Time Factors / Prognosis / Cesarean Section / Pregnancy Outcome / Endometrial Hyperplasia / Severity of Illness Index / Adult / Time Factors / Prognosis / Cesarean Section / Pregnancy Outcome / Endometrial Hyperplasia / Severity of Illness Index

Epidural labor analgesia in a patient receiving fondaparinux

Polysaccharides / Pregnancy / Humans / Female / Anticoagulants / Obstetric Anesthesia / Adult / Time Factors / Cesarean Section / Venous thromboembolism / Thoracic epidural analgesia / Obstetric Anesthesia / Adult / Time Factors / Cesarean Section / Venous thromboembolism / Thoracic epidural analgesia

Trombosis de vena ovárica y vena cava inferior asociada a endometritis en el puerperio

Computed Tomography / Pulmonary Embolism / Differential Diagnosis / Inferior Vena Cava / Cesarean Section / Ovary / Abdominal Pain / Early Diagnosis / Ovary / Abdominal Pain / Early Diagnosis

Anestesia obstétrica en Cataluña

Cesarean Section / Medicina Clinica

Placenta previa-accreta: Risk factors and complications

Obstetrics / Epidemiology / Comorbidity / Pregnancy / Complication / Humans / Smoking / Female / Risks / American / Risk factors / Risk Factor / Gynecology / Adult / Retrospective Studies / Cesarean Section / Risk Factors / Pregnancy Outcome / placenta accreta / Humans / Smoking / Female / Risks / American / Risk factors / Risk Factor / Gynecology / Adult / Retrospective Studies / Cesarean Section / Risk Factors / Pregnancy Outcome / placenta accreta

Operating on placental support: The ex utero intrapartum treatment procedure

Pediatric Surgery / Pediatric / Cesarean Section / Congenital Diaphragmatic Hernia / Airway Obstruction / Umbilical Cord

Pelvic organ support in pregnancy and postpartum

Adolescent / Pelvic Organ Prolapse / Prospective studies / Pregnancy / Humans / Female / Urogynecology / Risk factors / Adult / Pregnant Women / Cesarean Section / Risk Factors / Parity / Observational Study / Cross Sectional Studies / Uterine Prolapse / Severity of Illness Index / Female / Urogynecology / Risk factors / Adult / Pregnant Women / Cesarean Section / Risk Factors / Parity / Observational Study / Cross Sectional Studies / Uterine Prolapse / Severity of Illness Index
Copyright © 2017 DATOSPDF Inc.